Research Article

MitoQ Modulates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction via Regulating Nrf2 Signaling

Figure 2

MitoQ improved intestinal permeability and inhibited bacterial translocation during LPS-induce sepsis. (a) Serum FD-40 level was evaluated in vivo permeability. (b) Bacterial CFU was quantified in MLN, and each data point represents the CFU from each mouse. CFU: bacterial colony-forming units; MLN: mesenteric lymph nodes. Data are expressed as the . vs. control group; # vs. LPS group.
(a)
(b)